Eligibility and plan terms apply. Prescription required; prescriber extra.
Provider details and terms
Medication options
Semaglutide · Wegovy. Brand-name path.
Offer conditions
Eligible new self-pay patients: first two 0.25/0.5 mg pen fills $199 each through December 31, 2026, then $349 per four pens. Pill: $149 at 1.5 mg, $199 at 4 mg, $299 at 9/25 mg. HD pen $399.
Care and other fees
No manufacturer membership; prescriber may charge
Clinical support
Prescription required; your prescriber or a linked telehealth practice provides care.
Shipping
NovoCare home delivery or eligible retail pharmacy fulfillment.
Pharmacy
Manufacturer-backed brand-name supply; not compounded.
Payment & cancellation
Pay per prescription fill. Insurance savings have eligibility limits; government beneficiaries excluded from commercial savings.
Dose-related pricing
Pill price depends on dose; regular pen $349 after introductory fills.
State coverage
Manufacturer materials report nationwide pharmacy availability. This is a medication route, not state-licensed telehealth care; prescriber eligibility, stock and savings terms are separate.
HSA / FSA
Listed as eligible; confirm with your plan administrator.
Worth knowing: This is a medication/manufacturer savings route, not a bundled telehealth care provider. Clinical evaluation can cost extra.
These comments cover Wegovy medication and the NovoCare access route. Each excerpt identifies the service or medication experience being discussed.
The sample includes NovoCare ordering, payment and delivery accounts as well as medication experiences. Each excerpt identifies its scope; these are not reviews of one prescribing practice.
PositiveJuly 2026 (approximate)
“I’ve been on for over two years. I’ve had a good experience. I’ve lost 40lbs then plateaued, which was fine for me.”
Medication experience, not a review of NovoCare or the manufacturer customer service.
“Con: I forget to eat and then feel sick because I’m hungry. Highest dose made me toss my cookies once a week for at least a six months.”
IMPORTANT full comment is overall positive (self-reported 130-lb loss, says worth it) despite this adverse-experience excerpt; label mixed rather than purely negative.
“I find the side effects annoying and exhausting... and I seriously don't have it that bad. But I'm emetophobic so I'm deathly afraid of vomiting and nausea.”
Medication tolerability account; not a review of manufacturer service.
“Don't worry. Their system feels weird at the start but I'm now 3 refills in and it's fine.”
NovoCare follow-up after an initially slow January consent/order/shipping sequence: the same commenter now says three refills were fine and phone support easy. Mixed classification preserves both stages of their experience.
“My prescription was confirmed quickly, but have heard nothing since. That was over a week ago.”
NovoCare communication delay after initial confirmation. The later reply asking whether it improved is another person; no resolution from this commenter was established.
“NovoCare has been great for me! I usually receive a text from them a couple of hours after my prescriber sends them the script.”
NovoCare pharmacy fulfillment experience in a Wegovy pill discussion. This is about prescription processing, not medication efficacy or a prescribing practice.
“I got a text from NovoCare within 24 hours of my doctor sending them the rx.”
NovoCare first-order processing report. At the time of posting, the first delivery was scheduled for the following Tuesday and had not yet been received.
“I’ve been using NovoCare for 7 months without any hiccups”
Seven-month NovoCare service experience, offered in response to another user's processing difficulties. Excerpt excludes supportive wishes and makes no efficacy claim.
“My order only moved fast once my doc switched to eRx in their system.”
NovoCare intake account: commenter reports a slow fax process followed by faster electronic-prescription processing. This is historical experience, not instructions to change a prescription channel.
“My doctor has sent 3 different prescriptions in the last week trying to see if they will refill it. And every time I call, they say that they have not received it.”
NovoCare prescription-intake frustration in a semaglutide access discussion. Unverified individual account; a later participant in the thread notes their own prescriber had sent a prescription to a different, similarly named pharmacy.
Comments checked October 31, 2026. The score reflects the selected comments, not all customers. Older comments may describe different prices or services.